|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||108.07 - 110.25|
|52-week range||85.05 - 126.70|
|Beta (5Y monthly)||0.19|
|PE ratio (TTM)||36.06|
|Forward dividend & yield||2.79 (2.60%)|
|Ex-dividend date||25 Feb 2021|
|1y target est||N/A|
Yahoo Finance’s Anjalee Khemlani reports the latest updates on the coronavirus.
Dr. Jonathan Javitt, CEO of NeuroRX & adjunct professor at Johns Hopkins School of Medicine, joined Yahoo Finance to discuss the latest on covid-19.
Rebels are right that a £2m rise is pushing it – even for AstraZeneca’s superstar Fund managers tried to vote down Pascal Soriot’s package for fear of more boardroom pay inflation Demonstrators protesting outside AstraZeneca’s Macclesfield offices against its chief executive’s bonus. Photograph: Paul Ellis/AFP/Getty